• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.

作者信息

Beran Azizullah, Zink Evan, Mhanna Mohammed, Abugharbyeh Aya, Hanrahan Jennifer, Duggan Joan, Assaly Ragheb

机构信息

Department of Internal Medicine, University of Toledo, Toledo, Ohio, USA.

Department of Infectious Diseases, University of Toledo, Toledo, Ohio, USA.

出版信息

J Med Virol. 2021 Jul;93(7):4156-4160. doi: 10.1002/jmv.26970. Epub 2021 Apr 3.

DOI:10.1002/jmv.26970
PMID:33782995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250487/
Abstract
摘要

相似文献

1
Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在免疫功能低下患者中的传播性和病毒复制
J Med Virol. 2021 Jul;93(7):4156-4160. doi: 10.1002/jmv.26970. Epub 2021 Apr 3.
2
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.免疫功能低下患者中 SARS-CoV-2 的病毒持续排出。
J Infect Chemother. 2021 Feb;27(2):387-389. doi: 10.1016/j.jiac.2020.12.001. Epub 2020 Dec 4.
3
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.长期严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）在 3 名免疫功能低下患者中的传染性：从延长的病毒脱落到 SARS-CoV-2 再感染。
J Infect Dis. 2021 May 20;223(9):1522-1527. doi: 10.1093/infdis/jiab075.
4
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
5
Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients?新冠病毒感染者解除隔离时是否应采用实时荧光 RT-PCR 进行检测？
J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.06.030. Epub 2020 Jun 18.
6
COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.免疫功能低下宿主中的 COVID-19：活 SARS-CoV-2 的持续排出和多种突变的出现：一例报告。
Int J Infect Dis. 2022 Jan;114:178-182. doi: 10.1016/j.ijid.2021.10.045. Epub 2021 Oct 29.
7
Factors Associated with the Delayed Termination of Viral Shedding in COVID-19 Patients with Mild Severity in South Korea.与韩国轻症 COVID-19 患者病毒脱落延迟终止相关的因素。
Medicina (Kaunas). 2020 Nov 29;56(12):659. doi: 10.3390/medicina56120659.
8
SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.SARS-CoV-2 晚期脱落物在免疫功能低下宿主之间可能具有传染性。
Infect Dis (Lond). 2021 Nov;53(11):880-882. doi: 10.1080/23744235.2021.1939891. Epub 2021 Jun 17.
9
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.H1N1 暴露于 SARS-CoV-2 感染的恢复期可导致 hACE2 转基因小鼠肺部病理损伤加重。
Emerg Microbes Infect. 2021 Dec;10(1):1156-1168. doi: 10.1080/22221751.2021.1938241.
10
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.

引用本文的文献

1
Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence.免疫系统缺陷不会改变 SARS-CoV-2 的进化率，但会通过延长病毒持续时间促进突变的出现。
Viruses. 2024 Mar 13;16(3):447. doi: 10.3390/v16030447.
2
Reinfection with SARS-CoV-2 in a patient undergoing chemotherapy for lymphoma: Case report.一名正在接受淋巴瘤化疗的患者再次感染严重急性呼吸综合征冠状病毒2：病例报告。
J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):283-291. doi: 10.3138/jammi-2021-0036. eCollection 2022 Sep.
3
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.免疫功能低下患者早期新冠病毒病治疗的安全性及结果：一项单中心队列研究
Biomedicines. 2022 Aug 18;10(8):2002. doi: 10.3390/biomedicines10082002.
4
Whole-Genome Sequencing of SARS-CoV-2 Infection in a Cluster of Immunocompromised Children in Indonesia.印度尼西亚一群免疫功能低下儿童中新冠病毒感染的全基因组测序
Front Med (Lausanne). 2022 Mar 4;9:835998. doi: 10.3389/fmed.2022.835998. eCollection 2022.
5
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab.利妥昔单抗治疗后咽拭子 SARS-CoV-2 RT-PCR 阴性的肾移植受者发生严重的 SARS-CoV-2 感染复发。
Am J Transplant. 2022 Aug;22(8):2099-2103. doi: 10.1111/ajt.17000. Epub 2022 Mar 1.
6
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.免疫功能低下的成人血液病患者中 mRNA-1273 COVID-19 疫苗接种反应的定量分析。
Blood Adv. 2022 Mar 8;6(5):1537-1546. doi: 10.1182/bloodadvances.2021006917.
7
RNA reference materials with defined viral RNA loads of SARS-CoV-2-A useful tool towards a better PCR assay harmonization.具有明确 SARS-CoV-2 病毒 RNA 载量的 RNA 参考材料——一种实现更好 PCR 检测方法协调一致的有用工具。
PLoS One. 2022 Jan 20;17(1):e0262656. doi: 10.1371/journal.pone.0262656. eCollection 2022.
8
Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic Patient.一名症状轻微患者出现非典型的长时间病毒脱落及体内严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进化
Front Med (Lausanne). 2021 Nov 26;8:760170. doi: 10.3389/fmed.2021.760170. eCollection 2021.
9
Incidence of Mortality, Acute Kidney Injury and Graft Loss in Adult Kidney Transplant Recipients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis.2019年冠状病毒病成年肾移植受者的死亡率、急性肾损伤和移植物丢失发生率：系统评价和荟萃分析
J Clin Med. 2021 Nov 4;10(21):5162. doi: 10.3390/jcm10215162.
10
Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A report of two cases.在症状轻微的个体中持续存在有复制能力的 SARS-CoV-2：两例病例报告。
J Med Virol. 2021 Sep;93(9):5603-5607. doi: 10.1002/jmv.27021. Epub 2021 Apr 23.

本文引用的文献

1
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性：系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
2
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.癌症免疫抑制治疗后活的严重急性呼吸综合征冠状病毒2的脱落
N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1.
3
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.病例研究：一名患有癌症的无症状免疫功能低下个体长期感染性严重急性呼吸综合征冠状病毒2（SARS-CoV-2）脱落。
Cell. 2020 Dec 23;183(7):1901-1912.e9. doi: 10.1016/j.cell.2020.10.049. Epub 2020 Nov 4.
4
Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2.在 SARS-CoV-2 持续阳性逆转录聚合酶链反应结果的病例中推断病毒的活跃复制。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02277-20.
5
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.严重急性呼吸综合征冠状病毒2型在免疫功能低下宿主中的持续存在与演变
N Engl J Med. 2020 Dec 3;383(23):2291-2293. doi: 10.1056/NEJMc2031364. Epub 2020 Nov 11.
6
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.免疫功能低下患者中严重急性呼吸综合征冠状病毒 2 持续复制。
J Infect Dis. 2021 Jan 4;223(1):23-27. doi: 10.1093/infdis/jiaa666.
7
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.SARS-CoV-2 病毒培养及轻症冠状病毒病患者呼吸道标本的亚基因组 RNA
Emerg Infect Dis. 2020 Nov;26(11):2701-2704. doi: 10.3201/eid2611.203219. Epub 2020 Aug 4.
8
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.SARS-CoV-2 RNA 脱落持续时间及 COVID-19 患者病毒脱落时间延长的相关因素。
J Med Virol. 2021 Jan;93(1):506-512. doi: 10.1002/jmv.26280. Epub 2020 Jul 15.
9
Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.近期心脏移植术后患者 SARS-CoV-2 持续排出和 COVID-19 轻症经过。
Am J Transplant. 2020 Nov;20(11):3239-3245. doi: 10.1111/ajt.16133. Epub 2020 Jul 4.
10
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.感染 SARS-CoV-2 后的血清学特征：暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.